Flexible treatment of gestational diabetes mellitus adjusted according to intrauterine fetal growth versus treatment according to strict maternal glycemic parameters: a randomized clinical trial.

Manuela Fernández-López, José Eliseo Blanco-Carnero, Juan Manuel Guardia-Baena, Catalina de Paco-Matallana, Aurora Aragón-Alonso, Antonio Miguel Hernández-Martínez

Journal: BMJ open diabetes research & care 2023;10(6):e002915

PMID: 36593648

Abstract

INTRODUCTION

To compare the conventional treatment of gestational diabetes mellitus (GDM) with flexible treatment according to the measurement of fetal abdominal circumference (AC) in daily clinical practice.

RESEARCH DESIGN AND METHODS

Two hundred and sixty pregnant women diagnosed with GDM before week 34 were randomly placed in two groups: a control group, treated according to maternal capillary glycemia, and an experimental group, treated according to ultrasound parameters of fetal growth. The glycemic targets in the control group were blood glucose levels when fasting and 1 hour postprandial (<95/140 mg/dL). In the experimental group, glycemic targets depended on the percentile (p) of fetal AC: if AC p <75th, then blood glucose targets when fasting and at 1 hour postprandial were <120/180 mg/dL; and if AC p ≥75th, then the glycemic targets were <80/120 mg/dL. The follow-up of both groups was scheduled according to the GDM protocol of our diabetes and gestation unit.

RESULTS

The study was completed by 246 pregnant women, 125 in the control group and 121 in the experimental group. In the experimental group, insulin treatment and neonatal hypoglycemia were significantly lower (p=0.018 and p 0.035, respectively). No differences were observed in large and small infants according to gestational age. However, macrosomic infants were less frequent in the experimental group, although this difference did not reach statistical significance. In terms of gestation complications, the type of delivery and its complications and the rest of the neonatal complications analyzed, no significant differences were observed.

CONCLUSIONS

The treatment of flexible GDM according to the measurement of fetal AC is safe for the mother and the fetus and almost halves the number of pregnant women who require insulin treatment, without increasing the number of ultrasound checks or medical visits.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Address: Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain [email protected].; Obstetricia y Ginecología, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.; Biotecnología. Aplicaciones Sanitarias de Biociencias, Instituto Murciano de Investigación Biosanitaria, IMIB-Arrixaca, Murcia, Spain.; Endocrinología y Nutrición, Hospital Universitario Virgen de las Nieves, Granada, Spain.; Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Spain.; Medicina Interna: Endocrinología, Universidad de Murcia, Murcia, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.